BenefitsPRO: Employee Benefits News, Trends & Sales Tips

Congress' 2023 health care and retirement to-do list: What's on the regulatory agenda

By Alan Goforth

At the committee level, there is a lot of bipartisan activity for health care reform for 2023 that includes PBM reforms and insulin caps in the commercial market, as well as regulatory guidance on the new retirement bill SECURE 2.0.

Read Story

Update

Drug pricing battle: House and Senate both targeting pharmacy benefit managers

Update

Free preventive services will continue while ACA ruling is appealed, say insurers

Recommended Just For You

Update Stories

April 18, 2023

Workplace wellness at risk, as COVID public health emergency expires

Federal policy changes may have public health prevention ripple effects – from vaccination to screening rates to workplace flextime so workers can still have access to care – and company policies will now need be reevaluated.

Read

April 17, 2023

SECURE 2.0 compliance issues: Public sector DC plans seek 'urgent guidance' from IRS

The National Association of Government Defined Contribution Administrators sent a letter to the IRS and the Treasury, urging clarification on age-60 catch-up contributions and plan participation for part-time workers.

Read

April 14, 2023

The end of the COVID emergency: DOL offers guidance for employer health plans

Employers need to ensure that employees are informed about changes to their health benefits, regarding COVID testing and vaccines, and offer coverage to those affected by the suspension of Medicaid dis-enrollments.

Read

April 03, 2023

FTC's new rule banning non-competes: Comment period extended until April 19

Under the current language of the proposed rule, the ban would apply retroactively, so employers would have to notify current and former employees that the agreement is no longer valid.

Read

March 28, 2023

PBM drug pricing transparency reform bill headed to the full Senate

The bipartisan pharmacy benefit manager bill, which was approved by a Senate committee, would make it illegal to charge health plans and payers more for a prescription drug than what PBMs reimburse to the pharmacy.

Read

March 24, 2023

The U.S. health care system, post-COVID emergency: 4 key changes

When the public health emergency ends on May 11, it will institute sweeping changes across the health care system, from hospitals and testing labs to treatment for people recovering from addiction.

Read

March 20, 2023

Access to abortion pill in the balance, awaiting Texas federal judge's decision

Last week, the judge heard arguments in a case that will decide the safety of mifepristone, one of the drugs in the two-pill regimen that has been used by 5.6 million women since 2000, according to the FDA.

Read

‹ ‹ PREV 12 13 14 ... 16 › NEXT ›

Update

Top Update Stories

Congress' 2023 health care and retirement to-do list: What's on the regulatory agenda

Drug pricing battle: House and Senate both targeting pharmacy benefit managers

Free preventive services will continue while ACA ruling is appealed, say insurers

Recommended Just For You

Update Stories

Workplace wellness at risk, as COVID public health emergency expires

SECURE 2.0 compliance issues: Public sector DC plans seek 'urgent guidance' from IRS

The end of the COVID emergency: DOL offers guidance for employer health plans

FTC's new rule banning non-competes: Comment period extended until April 19

PBM drug pricing transparency reform bill headed to the full Senate

The U.S. health care system, post-COVID emergency: 4 key changes

Access to abortion pill in the balance, awaiting Texas federal judge's decision